Log in

Previous Entry

There's a bill in Congress right now that would require that clinical trials funded by the government be published, whether the medicine was approved or not.

This is a good idea because when the information gathered in these trials is not disclosed, it means that other inquiries can waste time going down blind alleys that have already been explored.

There's a good article on the bill at Pharmalot, which goes into more detail about why disclosing clinical trial information is a good idea.

The bill is currently before the
House Committee on Energy and Commerce. If you have a representative on the committee, and you think requiring that this information be published is a good idea, you might want to drop them a line.